• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[一例不可切除的肝细胞癌伴门静脉癌栓对DSM-TACE（可降解淀粉微球-经动脉化疗栓塞术）有反应的病例报告]

[A case report of unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus responding to DSM-TACE (degradable starch microspheres-transcatheter arterial chemoembolization)].

作者信息

Kirihara Masato, Nagashima Michio, Higuchi Kyoko, Tahira Hideaki, Tajima Masayuki

机构信息

Dept. of Surgery, Kawaguchi Kogyo General Hospital.

出版信息

Gan To Kagaku Ryoho. 2010 Nov;37(12):2705-7.

PMID:21224686
Abstract

A 56-year-old man was revealed to be HCC with portal vein tumor thrombus. Curative operation was impossible because we recognized many daughter lesions in the liver. Tumor marker was very high. DSM-TACE was conducted as the first line therapy. There was no remarkable side effect. After two-course, the size of HCC was decreased in CT and tumor marker was normalized. Generally speaking, a prognosis of HCC with portal vein tumor thrombus is poor. Hence, DSM-TACE is one of the effective therapies for HCC with portal vein tumor thrombus.

摘要

一名56岁男性被诊断为患有门静脉瘤栓的肝细胞癌。由于我们在肝脏中发现了许多子病灶，因此无法进行根治性手术。肿瘤标志物水平非常高。采用药物洗脱微球经动脉化疗栓塞术（DSM-TACE）作为一线治疗方法。没有明显的副作用。经过两个疗程后，CT显示肝细胞癌的大小减小，肿瘤标志物恢复正常。一般来说，伴有门静脉瘤栓的肝细胞癌预后较差。因此，DSM-TACE是治疗伴有门静脉瘤栓的肝细胞癌的有效疗法之一。

相似文献

1
[A case report of unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus responding to DSM-TACE (degradable starch microspheres-transcatheter arterial chemoembolization)].[一例不可切除的肝细胞癌伴门静脉癌栓对DSM-TACE（可降解淀粉微球-经动脉化疗栓塞术）有反应的病例报告]
Gan To Kagaku Ryoho. 2010 Nov;37(12):2705-7.
2
[Transcatheter arterial chemoembolization prolonged survival in a patient with advanced hepatocellular carcinoma accompanied by tumor thrombus of the portal vein trunk].经导管动脉化疗栓塞术延长了一名伴有门静脉主干肿瘤血栓的晚期肝细胞癌患者的生存期。
Gan To Kagaku Ryoho. 2010 Nov;37(12):2690-2.
3
[A case of diffuse invasive hepatocellular carcinoma associated with thrombosis of the main trunk of the portal vein in which hepatic transcatheter arterial chemoembolization concomitant to the use of degradable starch microspheres (DSM-TACE) was very effective].[一例伴有门静脉主干血栓形成的弥漫性浸润性肝细胞癌病例，其中经肝动脉化疗栓塞联合使用可降解淀粉微球（DSM-TACE）非常有效]
Gan To Kagaku Ryoho. 2006 Nov;33(12):1807-10.
4
[A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization].[经导管动脉化疗栓塞术治疗门静脉癌栓（Vp2）的肝细胞癌成功病例]
Gan To Kagaku Ryoho. 2006 Nov;33(12):1931-4.
5
Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.使用可降解淀粉微球进行动脉化疗栓塞及持续动脉输注5-氟尿嘧啶治疗肝细胞癌
Jpn J Clin Oncol. 2008 Sep;38(9):596-603. doi: 10.1093/jjco/hyn076.
6
[A case of advanced hepatocellular carcinoma with tumor thrombus treated by transarterial chemoembolization therapy using cisplatin (CDDP) with DSM and SAP-MS].[1例采用顺铂（CDDP）联合DSM及SAP-MS经动脉化疗栓塞治疗的晚期肝细胞癌伴肿瘤血栓病例]
Gan To Kagaku Ryoho. 2005 Oct;32(10):1477-80.
7
Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.经导管动脉化疗栓塞与化疗灌注治疗伴有主门静脉血栓形成的不可切除肝细胞癌。
Aliment Pharmacol Ther. 2009 Jun 15;29(12):1291-8. doi: 10.1111/j.1365-2036.2009.04016.x. Epub 2009 Apr 8.
8
[Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].三维适形低分割单次大剂量放疗联合经动脉化疗栓塞治疗肝细胞癌门静脉癌栓的疗效
Ai Zheng. 2004 Jul;23(7):825-8.
9
Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.辅助性经导管动脉化疗栓塞术可提高肝细胞癌合并门静脉癌栓患者肝切除术的疗效。
Am J Surg. 2009 Sep;198(3):313-8. doi: 10.1016/j.amjsurg.2008.09.026. Epub 2009 Mar 12.
10
[A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up].[1例门静脉第一分支及肝静脉主干内有瘤栓的肝细胞癌经肝动脉化疗栓塞术和肝动脉灌注化疗治疗——两年零六个月随访]
Gan To Kagaku Ryoho. 2005 May;32(5):667-70.

引用本文的文献

1
Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation.移植前治疗对等待肝移植的肝细胞癌患者的作用。
Cancers (Basel). 2022 Jan 13;14(2):396. doi: 10.3390/cancers14020396.
2
Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma.经动脉化疗栓塞术联合瘤内注射顺铂治疗肝细胞癌的可行性评估
Open Med (Wars). 2015 Dec 17;10(1):434-439. doi: 10.1515/med-2015-0075. eCollection 2015.